Tetrahydrobiopterin (BH4) functions as a cofactor for several important enzyme systems, and considerable evidence implicates BH4 as a key regulator of endothelial nitric oxide synthase (eNOS) in the setting of cardiovascular health and disease. BH4 bioavailability is determined by a balance of enzymatic de novo synthesis and recycling, versus degradation in the setting of oxidative stress. Augmenting vascular BH4 levels by pharmacological supplementation has been shown in experimental studies...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Tetrahydrobiopterin in cardiovascular health and disease.
If you are the owner of this record, you can report an update to it here: Report update to this record